Generalized MG should be suspected when clinicians see fluctuating, fatigable weakness ...

Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency has granted orphan drug designation to a small molecule intended to treat spinal ...

Rozanolixizumab improved muscle weakness and fatigue in myasthenia gravis patients, as shown in the MycarinG study using MG Symptoms PRO scales. Strong correlations were found between MG Symptoms PRO ...

The TikTok star, 37, was officially diagnosed with the terminal neurodegenerative disease in 2022 ...

- Topline data remains on track for second quarter of 2024 - MIAMI, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Nido Biosciences has announced positive results from a ...

With this study, investigators hoped to describe personality traits among individuals who have the autoimmune, neuromuscular disease. Findings of pronounced personality traits among individuals who ...

A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...

"Decreasing AMMO [active maximal mouth opening] over time is seen most often in patients with SMA type 2 with an estimated reduction of almost 1 mm per year...At this point, we propose that ...

MIAMI, July 27, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of ...

MIAMI, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of ...